AXA S.A.
- SEC CIK
- 0000898427
- Latest filing
- Aug 14, 2026
CBIO holding history
Crescent Biopharma, Inc. in every 13F filed by AXA S.A., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CBIO overviewAll 13F holders of CBIOFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −1,587,741−100.0% | Sold out | Holders |
| Q1 2024 | 1,587,741 | $4.76M | <0.1% | +4430.0% | Added | Holders |
| Q4 2023 | 1,587,298 | $3.75M | <0.1% | −38,400−2.4% | Reduced | Holders |
| Q3 2023 | 1,625,698 | $2.44M | <0.1% | −5,811−0.4% | Reduced | Holders |
| Q2 2023 | 1,631,509 | $2.84M | <0.1% | +22,448+1.4% | Added | Holders |
| Q1 2023 | 1,609,061 | $2.03M | <0.1% | +1,609,061 | New | Holders |